PRLD logo

Prelude Therapeutics Incorporated (PRLD) Cash From Investing

Annual CFI

-$34.65 M
-$116.34 M-142.41%

31 December 2023

PRLD Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFI

$10.73 M
-$15.39 M-58.91%

30 September 2024

PRLD Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFI

$75.81 M
-$4.31 M-5.38%

30 September 2024

PRLD TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRLD Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-142.4%-28.7%+284.8%
3 y3 years-5479.1%+104.1%+128.9%
5 y5 years-6449.3%--

PRLD Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-142.4%+86.9%-74.2%+104.1%-7.2%+128.7%
5 y5 years-142.4%+86.9%-74.2%+104.1%-7.2%+128.7%
alltimeall time-142.4%+86.9%-74.2%+104.1%-7.2%+128.7%

Prelude Therapeutics Incorporated Cash From Investing History

DateAnnualQuarterlyTTM
Sept 2024
-
$10.73 M(-58.9%)
$75.81 M(-5.4%)
June 2024
-
$26.12 M(-16.3%)
$80.12 M(-474.0%)
Mar 2024
-
$31.22 M(+303.6%)
-$21.42 M(-38.2%)
Dec 2023
-$34.65 M(-142.4%)
$7.74 M(-48.6%)
-$34.65 M(-15.6%)
Sept 2023
-
$15.04 M(-119.9%)
-$41.03 M(+19.0%)
June 2023
-
-$75.43 M(-519.1%)
-$34.47 M(-159.3%)
Mar 2023
-
$18.00 M(+1228.3%)
$58.14 M(-28.8%)
Dec 2022
$81.69 M
$1.35 M(-93.7%)
$81.69 M(+4.0%)
Sept 2022
-
$21.61 M(+25.8%)
$78.53 M(-138.6%)
June 2022
-
$17.18 M(-58.6%)
-$203.71 M(-7.9%)
DateAnnualQuarterlyTTM
Mar 2022
-
$41.55 M(-2403.1%)
-$221.27 M(-16.1%)
Dec 2021
-$263.80 M(>+9900.0%)
-$1.80 M(-99.3%)
-$263.80 M(+0.6%)
Sept 2021
-
-$260.63 M(>+9900.0%)
-$262.33 M(>+9900.0%)
June 2021
-
-$381.00 K(-61.4%)
-$1.87 M(+22.2%)
Mar 2021
-
-$986.00 K(+199.7%)
-$1.53 M(+145.9%)
Dec 2020
-$621.00 K(-20.4%)
-$329.00 K(+93.5%)
-$621.00 K(+112.7%)
Sept 2020
-
-$170.00 K(+304.8%)
-$292.00 K(+139.3%)
June 2020
-
-$42.00 K(-47.5%)
-$122.00 K(+52.5%)
Mar 2020
-
-$80.00 K
-$80.00 K
Dec 2019
-$780.00 K(+47.4%)
-
-
Dec 2018
-$529.00 K
-
-

FAQ

  • What is Prelude Therapeutics Incorporated annual cash flow from investing activities?
  • What is the all time high annual CFI for Prelude Therapeutics Incorporated?
  • What is Prelude Therapeutics Incorporated annual CFI year-on-year change?
  • What is Prelude Therapeutics Incorporated quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Prelude Therapeutics Incorporated?
  • What is Prelude Therapeutics Incorporated quarterly CFI year-on-year change?
  • What is Prelude Therapeutics Incorporated TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Prelude Therapeutics Incorporated?
  • What is Prelude Therapeutics Incorporated TTM CFI year-on-year change?

What is Prelude Therapeutics Incorporated annual cash flow from investing activities?

The current annual CFI of PRLD is -$34.65 M

What is the all time high annual CFI for Prelude Therapeutics Incorporated?

Prelude Therapeutics Incorporated all-time high annual cash flow from investing activities is $81.69 M

What is Prelude Therapeutics Incorporated annual CFI year-on-year change?

Over the past year, PRLD annual cash flow from investing activities has changed by -$116.34 M (-142.41%)

What is Prelude Therapeutics Incorporated quarterly cash flow from investing activities?

The current quarterly CFI of PRLD is $10.73 M

What is the all time high quarterly CFI for Prelude Therapeutics Incorporated?

Prelude Therapeutics Incorporated all-time high quarterly cash flow from investing activities is $41.55 M

What is Prelude Therapeutics Incorporated quarterly CFI year-on-year change?

Over the past year, PRLD quarterly cash flow from investing activities has changed by -$4.31 M (-28.66%)

What is Prelude Therapeutics Incorporated TTM cash flow from investing activities?

The current TTM CFI of PRLD is $75.81 M

What is the all time high TTM CFI for Prelude Therapeutics Incorporated?

Prelude Therapeutics Incorporated all-time high TTM cash flow from investing activities is $81.69 M

What is Prelude Therapeutics Incorporated TTM CFI year-on-year change?

Over the past year, PRLD TTM cash flow from investing activities has changed by +$116.84 M (+284.78%)